PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Bridgefront Capital, LLC's Holding History (CIK: 0001725690)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 4,545 Value ($000) $251 Avg Close $47.99 Range $39.60 - $57.70

Q4 2023

Shares 11,370 Value ($000) $261 Avg Close $17.50 Range $13.72 - $23.88

Q3 2022

Shares 12,084 Value ($000) $102 Avg Close $9.46 Range $7.68 - $11.97

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	4,545	$251	$47.99	$39.60 - $57.70
Q4 2023	11,370	$261	$17.50	$13.72 - $23.88
Q3 2022	12,084	$102	$9.46	$7.68 - $11.97